OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Delineating gene–environment effects using virtual twins of patients treated with clozapine
Sam Mostafa, Thomas M. Polasek, Chad A. Bousman, et al.
CPT Pharmacometrics & Systems Pharmacology (2022) Vol. 12, Iss. 2, pp. 168-179
Open Access | Times Cited: 10
Sam Mostafa, Thomas M. Polasek, Chad A. Bousman, et al.
CPT Pharmacometrics & Systems Pharmacology (2022) Vol. 12, Iss. 2, pp. 168-179
Open Access | Times Cited: 10
Showing 10 citing articles:
Beyond Population‐Level Targets for Drug Concentrations: Precision Dosing Needs Individual‐Level Targets that Include Superior Biomarkers of Drug Responses
Thomas M. Polasek, Richard Peck
Clinical Pharmacology & Therapeutics (2024) Vol. 116, Iss. 3, pp. 602-612
Open Access | Times Cited: 10
Thomas M. Polasek, Richard Peck
Clinical Pharmacology & Therapeutics (2024) Vol. 116, Iss. 3, pp. 602-612
Open Access | Times Cited: 10
Pharmacogenomics – a minor rather than major force in clinical medicine
Thomas M. Polasek
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 3, pp. 203-212
Closed Access | Times Cited: 5
Thomas M. Polasek
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 3, pp. 203-212
Closed Access | Times Cited: 5
Pharmacogenomics in psychiatry – the challenge of cytochrome P450 enzyme phenoconversion and solutions to assist precision dosing
Sam Mostafa, Thomas M. Polasek, Chad A. Bousman, et al.
Pharmacogenomics (2022) Vol. 23, Iss. 15, pp. 857-867
Open Access | Times Cited: 20
Sam Mostafa, Thomas M. Polasek, Chad A. Bousman, et al.
Pharmacogenomics (2022) Vol. 23, Iss. 15, pp. 857-867
Open Access | Times Cited: 20
Dealing With Variable Drug Exposure Due to Variable Hepatic Metabolism: A Proof‐of‐Concept Application of Liquid Biopsy in Renal Impairment
Amin Rostami‐Hodjegan, Zubida M. Al‐Majdoub, Yannick von Grabowiecki, et al.
Clinical Pharmacology & Therapeutics (2024) Vol. 116, Iss. 3, pp. 814-823
Open Access | Times Cited: 4
Amin Rostami‐Hodjegan, Zubida M. Al‐Majdoub, Yannick von Grabowiecki, et al.
Clinical Pharmacology & Therapeutics (2024) Vol. 116, Iss. 3, pp. 814-823
Open Access | Times Cited: 4
Amikacin Dosing Adjustment in Critically Ill Oncologic Patients: A Study with Real-World Patients, PBPK Analysis, and Digital Twins
Jerson L. Silva, Natália Valadares de Moraes, Rita de Cássia Elias Estrela, et al.
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 297-297
Open Access
Jerson L. Silva, Natália Valadares de Moraes, Rita de Cássia Elias Estrela, et al.
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 297-297
Open Access
Using Machine Learning to Individualize Treatment Effect Estimation: Challenges and Opportunities
Alicia Curth, Richard Peck, Eoin McKinney, et al.
Clinical Pharmacology & Therapeutics (2023) Vol. 115, Iss. 4, pp. 710-719
Open Access | Times Cited: 10
Alicia Curth, Richard Peck, Eoin McKinney, et al.
Clinical Pharmacology & Therapeutics (2023) Vol. 115, Iss. 4, pp. 710-719
Open Access | Times Cited: 10
Virtual twins for model‐informed precision dosing of clozapine in patients with treatment‐resistant schizophrenia
Sam Mostafa, Reza Rafizadeh, Thomas M. Polasek, et al.
CPT Pharmacometrics & Systems Pharmacology (2024) Vol. 13, Iss. 3, pp. 424-436
Open Access | Times Cited: 3
Sam Mostafa, Reza Rafizadeh, Thomas M. Polasek, et al.
CPT Pharmacometrics & Systems Pharmacology (2024) Vol. 13, Iss. 3, pp. 424-436
Open Access | Times Cited: 3
Seeing what is behind the smokescreen: A systematic review of methodological aspects of smoking interaction studies over the last three decades and implications for future clinical trials
Róbert Hermann, Amin Rostami‐Hodjegan, Ping Zhao, et al.
Clinical and Translational Science (2023) Vol. 16, Iss. 5, pp. 742-758
Open Access | Times Cited: 3
Róbert Hermann, Amin Rostami‐Hodjegan, Ping Zhao, et al.
Clinical and Translational Science (2023) Vol. 16, Iss. 5, pp. 742-758
Open Access | Times Cited: 3
Virtual twin for healthcare management
Thomas M. Polasek
Frontiers in Digital Health (2023) Vol. 5
Open Access | Times Cited: 3
Thomas M. Polasek
Frontiers in Digital Health (2023) Vol. 5
Open Access | Times Cited: 3
